US 7238525
Strategy for leukemia therapy
granted A61KA61K31/366A61K31/519
Quick answer
US patent 7238525 (Strategy for leukemia therapy) held by The Regents of the University of California expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/366, A61K31/519, A61K45/06, A61K48/00